Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Austin

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 8, 2000
First FDA approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defectsC E Ruiz, E H Austin, J P Cheatham, et al.
Circulation|June 1, 2000
First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defectsC E Ruiz, E H Austin, J P Cheatham, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Benefit of neurophysiologic monitoring for pediatric cardiac surgeryE H Austin, H L Edmonds, S M Auden, et al.
Circulation|September 1, 1981
Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exerciseR H Jones, P McEwan, G E Newman, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 8, 2000
First FDA approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defectsC E Ruiz, E H Austin, J P Cheatham, et al.
Circulation|June 1, 2000
First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defectsC E Ruiz, E H Austin, J P Cheatham, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Benefit of neurophysiologic monitoring for pediatric cardiac surgeryE H Austin, H L Edmonds, S M Auden, et al.
Circulation|September 1, 1981
Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exerciseR H Jones, P McEwan, G E Newman, et al.
Pageof 6